Prelude Therapeutics Incorporated · NASDAQ:PRLD

Baker Bros. Advisors LP reported a 23.50% stake in Prelude Therapeutics Incorporated (Schedule 13D/A)

Event Jun 12, 2025 · Filed Jun 13, 2025

Baker Bros. Advisors LP reported a 23.50% stake in Prelude Therapeutics Incorporated, 10,269,968 shares, with active intent on Jun 12, 2025. Filed Jun 13, 2025 (Schedule 13D/A).

Stake
23.50%
Shares
10,269,968
Intent
Active
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
Baker Bros. Advisors LP23.50%10,269,968
Baker Bros. Advisors (GP) LLC23.50%10,269,968
Julian C. Baker23.50%10,269,968
Felix J. Baker23.50%10,269,968

Source

View original at SEC

Related